Adults over age 65 who have been diagnosed with Alzheimer’s disease or other dementia are more than twice as likely to die from suicide compared to older adults
Poor sleep impacts the risk of long-term cognitive decline in Hispanic/Latino middle aged and older adults differently than it does in non-Hispanic adults, according to research led by University of Miami Miller School of Medicine neurology faculty and the largest long-term study of US Hispanic/Latinos to date.
Poor sleep impacts risk of long-term cognitive decline in Hispanic/Latino adults
Poor sleep impacts the risk of long-term cognitive decline in Hispanic/Latino middle aged and older adults differently than it does in non-Hispanic adults, according to research led by University of Miami Miller School of Medicine neurology faculty and the largest long-term study of U.S. Hispanic/Latinos to date.
During seven years of follow-up, Hispanics/Latinos were more likely to develop cognitive declines in processing speed, mental flexibility, and verbal memory, if they had sleep disordered breathing, such as obstructive sleep apnea, and long sleep duration of nine or more hours.
Grifols takes another step in the fight against Alzheimer s, partners with Ace to open first AMBAR Center in Barcelona
-
AMBAR Center combines Grifols more than 15 years of knowledge researching this devastating disease with the experience of the non-profit medical foundation Ace Alzheimer Center Barcelona in diagnosing and treating Alzheimer s patients, including application of AMBAR (Alzheimer Management by Albumin Replacement)
-
The AMBAR clinical program, based on periodic plasma exchange with albumin, has shown a delay in the cognitive and functional progression of Alzheimer s disease in mild-to-moderate patients
- Ace Alzheimer Center will manage the center, to be located on its premises in Barcelona. Grifols will partner with other leading medical institutions to open expected future centers in the EU, U.S. and China, obtaining AMBAR
Grifols takes another step in the fight against Alzheimer s, partners with Ace to open first AMBAR® Center in Barcelona
News provided by
Share this article
-
AMBAR
® Center combines Grifols more than 15 years of knowledge researching this devastating disease with the experience of the non-profit medical foundation Ace Alzheimer Center Barcelona in diagnosing and treating Alzheimer s patients, including application of AMBAR
® (Alzheimer Management by Albumin Replacement)
-
The AMBAR
® clinical program, based on periodic plasma exchange with albumin, has shown a delay in the cognitive and functional progression of Alzheimer s disease in mild-to-moderate patients
- Ace Alzheimer Center will manage the center, to be located on its premises in Barcelona. Grifols will partner with other leading medical institutions to open expected future centers in the EU, U.S. and China, obtaining AMBAR